Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02523118 · ClinicalTrials.gov registry record
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
A clinical trial of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- 1,350
- Enrollment target
- 19
- Study locations
NCT02523118: Recruiting study of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02523118 is a study of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 1,350 participants, above the 833-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (62% higher). The trial reports 19 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02523118, a study of Eosinophilic Esophagitis and Eosinophilic Gastroenteritis, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- 1,350 participants
- Enrollment target
- 19
- Study locations
Study Summary
The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based on how the cells look. We are aiming to compare different tissue components such as inflammatory cell types with clinical symptoms. We want to see if scores on standard questionnaires can give us an idea how well the person is doing.
Primary Outcome
Mucosal eosinophil levels are measured as eosinophils per high power field (eos/hpf). The primary outcome measure is to determine the change in mucosal eosinophil level (eos/hpf) and to determine if the change in mucosal eosinophil level in eos/hpf correlates with the change in scores on clinical outcome measure metrics.
Conditions Studied
Study Locations (19)
Colorado
- University of Colorado Denver - Aurora
- Children's Hospital Colorado - Denver
Illinois
- Northwestern University - Chicago
- Ann and Robert H. Lurie Children's Hospital of Chicago - Chicago
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- University of Pennsylvania - Philadelphia
Arizona
- Mayo Clinic Hospital - Phoenix
Arkansas
- Arkansas Children's Research Institute - Rogers
California
- Rady Children's Hospital - San Diego
Indiana
- Riley Children's Hospital - Indianapolis
Maryland
- National Institutes of Health (NIH) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,350 participants |
| Start Date | 2015-07-17 |
| Est. Completion | 2051-01-01 |
What NCT02523118 shows while recruiting
NCT02523118 is an observational study that tracks outcomes without assigning an intervention. Its 1,350 participants enrollment target places it among the larger protocols in the corpus, above the 833-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (62% higher).
The record links to 5 conditions, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 0 interventions.
NCT02523118 lists 19 locations in 16 states (Colorado, Illinois, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT02523118 about?
NCT02523118 is a clinical study titled "OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages". The purpose of this observational study is to find the best measures to define how well a person with eosinophilic disorder is doing. People with EoE, EoG, EoN and EoC normally undergo endoscopy and/or colonoscopy where cells are collected for microscopic analysis. Treatments are then decided based ...
What is the current status of trial NCT02523118?
This trial is currently recruiting. The enrollment target is 1,350 participants. The study started on 2015-07-17. Estimated completion is 2051-01-01.
What conditions does trial NCT02523118 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis, Eosinophilic Gastroenteritis, Eosinophilic Gastritis, Eosinophilic Colitis, Eosinophilic Gastrointestinal Disorders (EGIDs).
Who is sponsoring clinical trial NCT02523118?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02523118 being conducted?
This trial has 19 study locations across Arizona, Arkansas, California, Colorado, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02523118's enrollment target sits among peer trials
1,350 5th of 44 higher than 40 of 44 other Eosinophilic Esophagitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Characteristics and Inflammatory Markers in Children with Eosinophilic Esophagitis (EoE)
RECRUITING
-
Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
A Registry for the Food Allergy Community
RECRUITING
-
Patient-Centered Decision Support for Eosinophilic Esophagitis
RECRUITING · NA
-
Eosinophilic Gastrointestinal Disorders Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI